SCHEMBL25518667

SCHEMBL25518667

CNCc1cn(S(=O)(=O)c2cccnc2)c(-c2ccc(F)cc2F)c1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.40
▸ ALPL P05186 1/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35
▸ TUBB4B P68371 1/20 0.35
▸ TUBB3 Q13509 1/20 0.35
▸ TUBB2A Q13885 1/20 0.35
▸ TUBB8 Q3ZCM7 1/20 0.35
▸ TUBA3E Q6PEY2 1/20 0.35
▸ TUBA1A Q71U36 1/20 0.35
▸ TUBA1C Q9BQE3 1/20 0.35
▸ TUBB6 Q9BUF5 1/20 0.35
▸ TUBB2B Q9BVA1 1/20 0.35
▸ TUBB1 Q9H4B7 1/20 0.35
▸ NAMPT P43490 5/20 0.34
▸ ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30427684 0.94 POLB (0.39) POLBALPLCYP17A1TUBB4ATUBB
Abeprazan SCHEMBL29443418 0.88 HTR6 (0.39) MAPTKMT2AHTR6
Abeprazan SCHEMBL29719476 0.88 HTR6 (0.39) MAPTKMT2AHTR6
Abeprazan SCHEMBL18196939 0.88 HTR6 (0.39) MAPTKMT2AHTR6
SCHEMBL25314470 0.87 SLC6A4 (0.37) POLBKMT2AHTR6
SCHEMBL30250179 0.87 SLC6A4 (0.37) POLBKMT2AHTR6
Abeprazan SCHEMBL19385615 0.87 HTR6 (0.40) MAPTKMT2AHTR6
SCHEMBL27200255 0.86 HTR6 (0.39) POLBALDH1A1KDM4EMAPTKMT2A
SCHEMBL30250130 0.85 MEN1 (0.37) ALPLMAPTKMT2AHTT
SCHEMBL26650833 0.85 MEN1 (0.37) ALPLMAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023090942-A1 PYRROLE DERIVATIVE OR PHARMACEUTICALLY OR SITOLOGICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF GASTROINTESTINAL DISORDERS COMPRISING SAME AS ACTIVE INGREDIENT 하나제약 주식회사 2023-05-25 — — WO disclosed
Send feedback